K/S BI BIOMEDICAL VENTURE IV — Credit Rating and Financial Key Figures
CVR number: 28301022
Bredgade 40, 1260 København K
Income statement (kDKK)
2020 | 2021 | 2022 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | |||
| EBIT | |||
| Other financial expenses | -7.00 | -25.00 | -4.00 |
| Net income from associates (fin.) | -4 533.00 | -14.00 | |
| Pre-tax profit | -4 540.00 | -39.00 | -4.00 |
| Net earnings | -4 540.00 | -39.00 | -4.00 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 2 320.00 | ||||
| Investments total | 2 320.00 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 3.00 | 2.00 | |||
| Short term receivables total | 3.00 | 2.00 | |||
| Cash and bank deposits | 581.00 | 12.00 | 8.00 | 5.00 | 6.00 |
| Cash and cash equivalents | 581.00 | 12.00 | 8.00 | 5.00 | 6.00 |
| Balance sheet total (assets) | 2 901.00 | 12.00 | 8.00 | 8.00 | 8.00 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 202 500.00 | 202 500.00 | 202 500.00 | 202 500.00 | 202 500.00 |
| Retained earnings | - 195 059.00 | - 202 449.00 | - 202 488.00 | - 202 492.00 | - 202 492.00 |
| Profit of the financial year | -4 540.00 | -39.00 | -4.00 | ||
| Shareholders equity total | 2 901.00 | 12.00 | 8.00 | 8.00 | 8.00 |
| Non-current liabilities total | |||||
| Current liabilities total | |||||
| Balance sheet total (liabilities) | 2 901.00 | 12.00 | 8.00 | 8.00 | 8.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.